Article
Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome.
Physiological research - 1 Jan 2006
Stancáková A, Baldaufová L, Javorský M, Kozárová M, Salagovic J, Tkác I
Abstract excerpt
Dyslipidemia in the metabolic syndrome (MS) is considered to be one of the most important risk factors for atherosclerosis. It is characterized by hypertriglyceridemia, low concentration of plasma HDL-cholesterol, predominance of small dense LDL particles and an increased concentration of plasma apolipoprotein B (apoB). The pathogenesis of this type of dyslipidemia is partially explained, but its genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
